^
Association details:
Biomarker:No biomarker
Cancer:Ewing Sarcoma
Drug:cyclophosphamide (Alkylating agent) +
topotecan (Topoisomerase I inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
11/20/2020
Excerpt:
Ewing sarcoma: Second-line therapy (relapsed/refractory or metastatic disease)…Preferred Regimens…Cyclophosphamide and topotecan